Home Melt Pharmaceuticals

Melt Pharmaceuticals

acquired
Series B
Analgesic Drug Developer
Basic
Enterprise Profile

Basic Information

Melt Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is dedicated to developing and commercializing patented sublingual, needle-free, and opioid-free procedural sedation and analgesic drugs to improve the experience of patients undergoing ophthalmic surgeries. Our novel patented fast-dissolving sublingual tablets provide a needle-free and opioid-free solution for both patients and caregivers.
Melt Pharmaceuticals, Inc.
Nashville,Tennessee,United States of America
less than 15 people
January 01, 2019
info@meltpharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Ophthalmology Therapeutic Products Operating Room
Application Scenarios
Chemical Drug Innovative Drugs